Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neutropenia × Gentamicins × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neuroma, Acoustic 3 Surgical Wound Infection 2 Stomatitis 2 Nasopharyngeal Carcinoma 2 Sepsis 1 Neutropenia 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1

Interventions

Filgrastim 7 pegfilgrastim 5 pegylated granulocyte colony-stimulating factor 4 Cytarabine 4 Leucovorin 3 Fluorouracil 3 Ciprofloxacin 3 Cefepime 3 Vancomycin 2 Piperacillin, Tazobactam Drug Combination 2 Methylprednisolone 2 Irinotecan 2 Etoposide 2 Daptomycin 2 Cisplatin 2 Amikacin 2 ziprasidone 1 trilaciclib 1 trifluridine tipiracil drug combination 1 sargramostim 1 niraparib 1 lintuzumab 1 leridistim 1 isavuconazole 1 fludarabine phosphate 1 flt3 ligand protein 1 fish oil triglycerides 1 etoposide phosphate 1 eravacycline 1 ceftolozane, tazobactam drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01931592 2017-05-08

CLEAR

University of Cologne

Phase 2/3 Terminated

Neoplasms, Neutropenia, Sepsis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡